URGN
Urogen Pharma Ltd
Price:  
10.39 
USD
Volume:  
274,190.00
Israel | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

URGN Stock Forecast & Price Target

URGN Stock Price Forecast

The average stock forecast for Urogen Pharma Ltd (URGN) in the next 12 months is 35.55 USD. This price target corresponds to an upside of 230.74%. The range of stock forecasts for URGN is 22.22 - 57.75 USD. Based on the ratings of 13 analysts, the consensus recommendation for URGN is BUY.
Target Low Average Median High
Price (USD) 22.22 35.55 35.70 57.75
Upside 106.70% 230.74% 232.09% 437.21%

Recommendation Trends

The latest consensus rating for URGN is "BUY". This is the average recommendation of 13 analysts: 0 strong sell, 0 sell, 2 hold, 6 buy, 5 strong buy. In the previous period, 13 analysts also majorly recommmended "BUY" for URGN.

URGN Financial Stock Forecast

Revenue This Year
125.34M
38.65%
from 90.40M
Revenue Next Year
274.11M
118.69%
from 125.34M
EPS This Year
-2.96
7.60%
from -2.75
EPS Next Year
-0.64
-78.39%
from -2.96